Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a multi-component local anesthetic mixture used for peribulbar block in ophthalmic surgeries, specifically anterior segment procedures. It combines two amide-type local anesthetics, **lidocaine** (fast-onset) and **bupivacaine** (long-acting), with **hyaluronidase**, an enzyme that acts as a spreading agent to enhance the dispersion of the anesthetics through the orbital tissues. **Fentanyl**, a potent synthetic opioid, is added as an adjuvant to enhance the quality of the block, provide supplemental analgesia, and potentially prolong the duration of postoperative pain relief. The mixture is typically administered via peribulbar injection to achieve akinesia and anesthesia of the eye.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fentanyl + lidocaine + bupivacaine + hyaluronidase.